BRGX (BioRegenx) Common Stock : $0.96 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Common Stock?

BioRegenx's quarterly common stock stayed the same from Mar. 2024 ($0.96 Mil) to Jun. 2024 ($0.96 Mil) and stayed the same from Jun. 2024 ($0.96 Mil) to Sep. 2024 ($0.96 Mil).

BioRegenx's annual common stock stayed the same from Dec. 2021 ($0.27 Mil) to Dec. 2022 ($0.27 Mil) but then increased from Dec. 2022 ($0.27 Mil) to Dec. 2023 ($0.28 Mil).

BioRegenx Common Stock Historical Data

The historical data trend for BioRegenx's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Common Stock Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.10

0.27

0.28

BioRegenx Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															0.28	0.28	0.96	0.96	0.96

BioRegenx Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.